Neurorehabilitation News

The FDA has approved Aqneursa as an oral treatment for neurological symptoms associated with Niemann-Pick disease type C, a rare genetic disease, in adults and children weighing at least 15 kg, according to a press release.

ORLANDO, Fla. — An algorithm for standardizing myasthenia gravis diagnosis during telehealth is feasible, but it requires additional testing and validation, according to researchers.

ORLANDO, Fla. — Cell-based therapies and enzyme inhibitors currently in development are likely to become the next-generation treatments for ambulatory and non-ambulatory forms of muscular dystrophy, according to a speaker.

ORLANDO, Fla. — Glymphatic function, as measured by an index of system clearance, is associated with rates of cognitive and motor decline as well as disability worsening in Parkinson’s disease, according to a poster.

Research into the relationship between rising temperatures and rates of violence in different settings has existed for decades, according to Jack Rozel, MD, MSL.

The FDA announced in a press release that it has approved Miplyffa to treat neurological symptoms associated with Niemann-Pick disease type C in patients aged 2 years and older.

ORLANDO, Fla. — For stroke survivors, participation in preventive health behaviors, such as adhering to blood pressure medication and physical activity, depended on their outcome expectations, self-efficacy and agency, data show.

ORLANDO, Fla. — Patients with MS who developed paramagnetic rim lesions declined more rapidly, but implementing disease-modifying therapies earlier could reduce the burden of disease progression, data show.

A Korean study identified a 22% increased risk for seizure among young children who were prescribed first-generation antihistamines, according to findings published in JAMA Network Open.

ORLANDO, Fla. — In a cohort of South American young adults, those who smoked or vaped recorded lower scores on a cognitive assessment vs. those who did not, with a stronger correlation found between vapers and lower cognitive scores, data show.